Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research
- 638 Downloads
Low grade gliomas affecting the visual pathway, commonly referred to as optic pathway gliomas (OPGs), have a relatively high survival rate but can cause significant vision loss. While previous treatment outcomes for tumors of the central nervous system have focused primarily on changes in tumor size or patient survival, more recently preservation of vision has also become a primary objective when treating these tumors. Visual acuity (VA) is the most testable and reliable visual parameter in young children with OPGs. Unfortunately, standardized VA assessments have neither been employed to make treatment decisions nor used as primary outcomes in clinical trials. The lack of a standardized VA assessment has also hindered the ability to interpret and compare results between studies. It is essential that all members of the multidisciplinary care team (i.e., pediatric neuro-oncologist, neurologist, neurosurgeon, and ophthalmologist) can accurately interpret VA results and properly use them to guide management decisions. Specifically, determining what constitutes a significant change in VA and the factors that may influence these results should be incorporated into collective team recommendations. This review describes the VA assessment in children with OPGs and proposes a standardized VA testing protocol for future pediatric OPG clinical treatment trials.
KeywordsOptic nerve glioma Juvenile pilocytic astrocytoma Visual acuity Visual pathways
Conflict of Interest
All authors declare they have no conflict of interest.
- 1.Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol 14:790–797 Google Scholar
- 11.Dobson V, Quinn GE, Tung B, Palmer EA, Reynolds JD (1995) Comparison of recognition and grating acuities in very-low-birth-weight children with and without retinal residua of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Invest Ophthalmol Vis Sci 36(3):692–702PubMedGoogle Scholar
- 12.Adoh TO, Woodhouse JM, Oduwaiye KA (1992) The Cardiff test: a new visual acuity test for toddlers and children with intellectual impairment. A preliminary report. Optom Vis Sci 69 (6):427–432Google Scholar
- 13.Dobson V, Quinn GE, Siatkowski RM, Baker JD, Hardy RJ, Reynolds JD, Trese MT, Tung B (1999) Agreement between grating acuity at age 1 year and Snellen acuity at age 5.5 years in the preterm child. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Invest Ophthalmol Vis Sci 40(2):496–503PubMedGoogle Scholar
- 19.Liu GT, Volpe NJ, Galetta SL (2010) Neuro-ophthalmology: diagnosis and management. 2nd edn. Saunders Elsevier, LondonGoogle Scholar